Switzerland: Fight Against Breast Cancer Integra Donates 20,000 Dollars to Cancer Research
When Integra Biosciences launched the Pipetgirl in 2015, the company pledged to donate $ 15 from every sale to internationally renowned research institutes dedicated to finding a cure for breast cancer. The company’s latest donation of about $ 20,000 has been awarded to the Swiss Cancer League (Krebsliga Schweiz).
Zizers/Switzerland — The sales of Integra's Pipetgirl pipetting controller contribute to cancer research. The latest donation will be used by the Swiss Cancer League to help fund a project investigating the link between E3 ubiquitin ligases and breast carcinoma. The research, being conducted at ETH Zurich, aims to develop a comprehensive pre-clinical model of hGID E3 ubiquitin ligase function — which is highly over-expressed in up to 55 % of aggressive breast, ovarian and prostate cancers — to help unravel its role in tumor progression and metastasis in breast cancer cells. This model will then be used to develop prognostic markers of cancer progression, and to screen for compounds that may form the basis of a future therapeutic intervention. Overall, sales of the Pipetgirl pipetting controller have now led to over $ 30,000 in donations to cancer research institutes globally.